Applied Graphene Materials gets first patent production process
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Applied Graphene Materials gets first patent for production process

5:48 AM, 18th June 2015
Applied Graphene Materials gets first patent for production process

REDCAR, UK: Producer of specialty graphene materials Applied Graphene Materials Plc said that it has received patent approval from the Japanese patent office in respect of its graphene production process.

The patent covers the proprietary process used by the group for manufacturing graphene nanoplatelets.

This approval is the first of the group’s patent applications to be granted. Applications relating to the production process have been made in a total of five other geographic territories and these remaining applications continue to be pursued.

“The granting of this first patent for the graphene production process confirms the proprietary nature of our process. We anticipate that Japan will be an important market for the group,” said Jon Mabbitt, Chief Executive Officer, Applied Graphene Materials.

“We are continuing to build on our existing platform of intellectual property and know how, concerning both the production of graphene and formatting graphene dispersions, to provide the greatest enhancements and performance benefits for our partners and customers,” he added.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Capital Southwest subsidiary files for spin-off

DALLAS, US: Capital Southwest Corporation said that its wholly-owned subsidiary, CSW Industrials Inc, has filed a registration statement with the Secu ...

Read more
Shell, BG $70 billion deal crosses key milestone with US clearance

LONDON, UK: US regulators have given the green light for Royal Dutch Shell’s proposed $70 billion acquisition of British rival BG Group, the fir ...

Read more
Allergan to buy Kythera Biopharmaceuticals for $2.1 billion

DUBLIN, IRELAND/WESTLAKE VILLAGE, US: Allergan Plc said that it will buy Kythera Biopharmaceuticals Inc, a company focussed on aesthetics medicine mar ...

Read more
AkzoNobel, Evonik form chlor-alkali investment joint venture in Germany

AMSTERDAM, NETHERLANDS: AkzoNobel NV and Evonik Industries AG said they will jointly build and operate a new membrane electrolysis facility for potass ...

Read more
Recipharm acquires Ontarget, extends preclinical development services

JORDBRO, SWEDEN: Recipharm AB said that it has completed the acquisition of Ontarget Chemistry AB, a contract research organization that offers synthe ...

Read more
Huber acquires flame-retardant technology from Floridienne Group

ATLANTA, US: Huber Engineered Materials (HEM), a division of J M Huber Corporation said it has acquired the Safire nitrogen and phosphorus fire retard ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X